GOLM1 and prostate carcinoma: By replacing the endogenous E1A promoter with GOLPH2 (also known as GP73), E1B 55kD Ad deletion induces significant cytotoxic effects in prostate cancer stem cell (CSC)-like cells through GP73 overexpression and exhibits stronger oncolytic effects (71).